COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation (IMPACT-AFib)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03259373
Recruitment Status : Active, not recruiting
First Posted : August 23, 2017
Last Update Posted : April 29, 2020
Duke Clinical Research Institute
HealthCore, Inc.
Clinical Trials Transformation Initiative
Humana, Inc
Aetna, Inc.
OptumInsight Life Sciences, Inc.
Food and Drug Administration (FDA)
Information provided by (Responsible Party):
Richard Platt, Harvard Pilgrim Health Care

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2021